Alerts will be sent to your verified email
Verify EmailNone
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Super Religare Laboratories Ltd offers the most comprehensive range of diagnostic facilities that cover an extensive range of specialties. Apart from pathology services SRL also provides a complete range of radiology modalities including Computed Tomography (CT), Diagnostic Radiology (X- Ray), Magnetic Resonance Imaging (MRI), Ultrasound and Positron Emission Tomography (“PET”).
Agilus Diagnostics major competitors are Dr. Reddy's Lab, Concord Drugs, Bharat Parenterals, Chandra Bhagat Pharm, Shanmuga Hospital, TTK Healthcare, Venus Remedies.
Market Cap of Agilus Diagnostics is ₹0 Crs.
While the median market cap of its peers are ₹927 Crs.
Agilus Diagnostics seems to be less financially stable compared to its competitors.
Altman Z score of Agilus Diagnostics is 0 and is ranked 8 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Claude
|
